The Section of Diabetes and Endocrinology at the University of Oklahoma Health Sciences Center is a core component of the Harold Hamm Diabetes Center at OU Medicine. Our clinical work encompasses the full spectrum of Diabetes and Endocrinology, including thyroid, adrenal, pituitary, bone, gonadal, and metabolic disorders. Outpatients are seen by physician referral, and have the opportunity to participate in clinical trials. Diabetes services are undergoing rapid expansion in collaboration with many other disciplines and partners on and off campus. Our goal is a state-wide effort to improve the lives of all people affected by diabetes and other endocrine disorders.
Our professional educational programs are aimed not only at medical students, residents, and fellows, but also at the broad spectrum of health care providers in hospitals and in the community who must work as a team to provide first class clinical care. We also place a major emphasis on education of communities, patients, their families, the general public, and makers of policies that affects community health.
Our clinical fellowship program, with six RRC-approved positions, seeks academically-oriented physicians for 2-, 3- and 4-year training programs. There are opportunities for experience of clinical and basic science research during the fellowship.
Our research program is a cornerstone of the Section. Its major emphasis is on diabetes and its vascular complications (eye disease, kidney disease, neuropathy, and accelerated atherosclerosis (hardening of the arteries)). We conduct clinical and basic science research with strong emphases on collaborations between clinicians and basic scientists, on linking different disciplines that are relevant to diabetes, on building partnerships with communities, particularly minority communities that are severely afflicted by diabetes, and on involving trainees in research. Our program has brought more than 40 new extra-mural grants and many new investigators to our Section in the past four years. Two major, five year NIH program grants were awarded in late 2007: a “Diabetes Center of Biologic Research Excellence”, and in collaboration with the OU College of Public Health, an “Oklahoma Center on American Indian Diabetes Health Disparities.” In 2012 the CoBRE "Diabetes Center of Biologic Research Excellence" was awarded a five year renewal under the leadership of Dr. Jian-Xing Ma.